J. Goldman & CO LP Spring Works Therapeutics, Inc. Call Options Transaction History
J. Goldman & CO LP
- $3.27 Billion
- Q2 2024
Call Options
1 transactions
Others Institutions Holding SWTX
# of Institutions
220Shares Held
66.8MCall Options Held
64.7KPut Options Held
150K-
Vanguard Group Inc Valley Forge, PA6.54MShares$196 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$168 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.7MShares$111 Million4.57% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.6MShares$108 Million0.02% of portfolio
-
Boxer Capital, LLC San Diego, CA3.42MShares$102 Million7.16% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $1.87B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...